Cellebrite DI (CLBT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cellebrite DI (CLBT) has a cash flow conversion efficiency ratio of 0.170x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($82.23 Million) by net assets ($484.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cellebrite DI liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Cellebrite DI - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Cellebrite DI's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cellebrite DI Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cellebrite DI ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
|
0.065x |
|
Hyundai Steel
KO:004020
|
0.027x |
|
Dana Inc
NYSE:DAN
|
0.441x |
|
Growthpoint Properties Ltd
JSE:GRT
|
0.036x |
|
Jilin Power Share Co Ltd
SHE:000875
|
0.102x |
|
Qingdao Gon Technology Co Ltd
SHE:002768
|
0.007x |
|
Shufersal
TA:SAE
|
0.144x |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
0.029x |
Annual Cash Flow Conversion Efficiency for Cellebrite DI (2019–2025)
The table below shows the annual cash flow conversion efficiency of Cellebrite DI from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Cellebrite DI worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $484.32 Million | $168.96 Million | 0.349x | -11.31% |
| 2024-12-31 | $336.02 Million | $132.17 Million | 0.393x | -86.81% |
| 2023-12-31 | $34.21 Million | $102.06 Million | 2.983x | +970.84% |
| 2022-12-31 | $73.86 Million | $20.58 Million | 0.279x | +156.68% |
| 2021-12-31 | $-73.35 Million | $36.05 Million | -0.492x | -147.15% |
| 2020-12-31 | $63.80 Million | $66.51 Million | 1.042x | +280.11% |
| 2019-12-31 | $58.83 Million | $16.13 Million | 0.274x | -- |
About Cellebrite DI
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exp… Read more